FDA moves to facilitate personalized therapies for rare diseases

Source: Washington Examiner · Bias: Center Right

Summary

The Food and Drug Administration is making it possible for pharmaceutical companies to produce bespoke medicines for individual patients, an effort to revolutionize the standard of care for rare diseases.  Trump administration officials announced on Monday new draft guidance from the FDA that would update approval standards for personalized genetic medicines, creating a new approval […]

Related Coverage

More Headlines From February 23, 2026

FDA moves to facilitate personalized therapies for rare diseases
Washington Examiner

FDA moves to facilitate personalized therapies for rare diseases

Center Right

The Food and Drug Administration is making it possible for pharmaceutical companies to produce bespoke medicines for individual patients, an effort to revolutionize the standard of care for rare diseases.  Trump administration officials announced on Monday new draft guidance from the FDA that would update approval standards for personalized genetic medicines, creating a new approval […]

FDA moves to facilitate personalized therapies for rare diseases | ParallaxNews.io